Home › Compare › XBIOW vs O

XBIOW vs O: Dividend Comparison 2026

XBIOW yields 11.40% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 XBIOW wins by $8.2K in total portfolio value
10 years
XBIOW
XBIOW
● Live price
11.40%
Share price
$17.54
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$42.5K
Annual income
$2,326.31
Full XBIOW calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.18
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,098.20
Full O calculator →

Portfolio growth — XBIOW vs O

📍 XBIOW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodXBIOWO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, XBIOW + O cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
XBIOW pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

XBIOW
Annual income on $10K today (after 15% tax)
$969.21/yr
After 10yr DRIP, annual income (after tax)
$1,977.36/yr
O
Annual income on $10K today (after 15% tax)
$448.90/yr
After 10yr DRIP, annual income (after tax)
$4,333.47/yr
At 15% tax rate, O beats the other by $2,356.11/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of XBIOW + O for your $10,000?

XBIOW: 50%O: 50%
100% O50/50100% XBIOW
Portfolio after 10yr
$38.3K
Annual income
$3,712.26/yr
Blended yield
9.68%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

XBIOW
No analyst data
Altman Z
-29.7
Piotroski
3/9
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.6% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

XBIOW buys
0
O buys
0
No recent congressional trades found for XBIOW or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricXBIOWO
Forward yield11.40% ✓5.28%
Annual dividend / share$2.00$3.23 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1% ✓
Portfolio after 10y$42.5K ✓$34.2K
Annual income after 10y$2,326.31$5,098.20 ✓
Total dividends collected$17.2K$20.7K ✓
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: XBIOW vs O ($10,000, DRIP)

YearXBIOW PortfolioXBIOW Income/yrO PortfolioO Income/yrGap
1← crossover$11,840$1,140.25$10,818$607.86+$1.0K → XBIOW
2$13,931$1,261.76$11,786$741.30+$2.1K → XBIOW
3$16,293$1,387.43$12,944$910.50+$3.3K → XBIOW
4$18,951$1,516.57$14,343$1,127.28+$4.6K → XBIOW
5$21,926$1,648.49$16,053$1,408.17+$5.9K → XBIOW
6$25,243$1,782.51$18,167$1,776.65+$7.1K → XBIOW
7$28,928$1,917.94$20,815$2,266.60+$8.1K → XBIOW
8$33,007$2,054.14$24,179$2,927.66+$8.8K → XBIOW
9$37,508$2,190.46$28,521$3,833.95+$9.0K → XBIOW
10$42,460$2,326.31$34,218$5,098.20+$8.2K → XBIOW

XBIOW vs O: Complete Analysis 2026

XBIOW — Stock

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

Full XBIOW Calculator →

O — REIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this XBIOW vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

XBIOW vs SCHDXBIOW vs JEPIXBIOW vs KOXBIOW vs MAINXBIOW vs STAGXBIOW vs ADCXBIOW vs NNNXBIOW vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.